OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Brian McGee (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to John Barratt (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Gerald Berstein, M.D. (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Peter Amanatides (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Mark Fletcher (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
DATED 17 DECEMBER 2004Termination Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
IN CONSIDERATION OF THE MUTUAL COVENANTS CONTAINED HEREIN, AND OTHER GOOD AND VALUABLE CONSIDERATION, THE RECEIPT AND ADEQUACY OF WHICH ARE HEREBY ACKNOWLEDGED, IT IS HEREBY AGREED AS FOLLOWS:
OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Rose Perri (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
Generex Biotechnology CorporationGenerex Biotechnology Corp • June 14th, 2005 • Pharmaceutical preparations
We make reference to the Promissory Note & Agreement (the “Note”) dated April 4, 2005 in the principal amount of One Hundred Thousand Dollars ($100,000) executed and delivered by Generex Biotechnology Corporation (the “Borrower”) in favour of Omicron Master Trust (the “Holder”).
OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Mark Fletcher (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
Generex Biotechnology Corporation Toronto, Ontario Canada M5J 2G2Generex Biotechnology Corp • June 14th, 2005 • Pharmaceutical preparations
We make reference to the employment agreement (the “Agreement”) made as of the 1st day of April, 2002 by and between you and Generex Biotechnology Corporation. The purpose of this letter is to confirm our mutual agreement to amend the Agreement as follows:
OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Anna Gluskin (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
PROMISSORY NOTE & AGREEMENTGenerex Biotechnology Corp • June 14th, 2005 • Pharmaceutical preparations
FOR VALUE RECEIVED, Generex Biotechnology Corporation (the “Borrower”) hereby acknowledges itself indebted and promises to pay to Omicron Master Trust (the “Holder”), at 650 5th Ave., 24th Floor, New York, New York 10019 the principal sum of One Hundred Thousand Dollars ($100,000) in lawful money of the United States of America.
OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Anna Gluskin (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Mindy J. Allport-Settle (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
OPTION AGREEMENTOption Agreement • June 14th, 2005 • Generex Biotechnology Corp • Pharmaceutical preparations
This Option Agreement evidences the grant of a stock option (the "Option") to purchase shares of common stock, par value $.001 (the "Company Stock"), of Generex Biotechnology Corporation (the "Company") granted to Rose Perri (the "Optionee") pursuant to the Generex Biotechnology Corporation 2001 Stock Option Plan (the “Plan”), a copy of which is attached to this Option Agreement and incorporated into this Option Agreement by reference. The Option is subject to the terms, conditions, limitations and restrictions set forth in the Plan, including the following:
